KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Bristol Myers Squibb (BMY) Enterprise Value (2016 - 2025)

Historic Enterprise Value for Bristol Myers Squibb (BMY) over the last 17 years, with Q3 2025 value amounting to -$16.5 billion.

  • Bristol Myers Squibb's Enterprise Value fell 10475.36% to -$16.5 billion in Q3 2025 from the same period last year, while for Sep 2025 it was -$16.5 billion, marking a year-over-year decrease of 10475.36%. This contributed to the annual value of -$10.8 billion for FY2024, which is 1160.74% up from last year.
  • Bristol Myers Squibb's Enterprise Value amounted to -$16.5 billion in Q3 2025, which was down 10475.36% from -$13.5 billion recorded in Q2 2025.
  • In the past 5 years, Bristol Myers Squibb's Enterprise Value ranged from a high of -$6.6 billion in Q2 2024 and a low of -$16.9 billion during Q4 2021
  • For the 5-year period, Bristol Myers Squibb's Enterprise Value averaged around -$11.5 billion, with its median value being -$11.7 billion (2025).
  • Its Enterprise Value has fluctuated over the past 5 years, first skyrocketed by 4560.51% in 2022, then crashed by 10531.9% in 2025.
  • Bristol Myers Squibb's Enterprise Value (Quarter) stood at -$16.9 billion in 2021, then soared by 45.61% to -$9.2 billion in 2022, then tumbled by 32.94% to -$12.2 billion in 2023, then increased by 11.61% to -$10.8 billion in 2024, then tumbled by 52.27% to -$16.5 billion in 2025.
  • Its Enterprise Value stands at -$16.5 billion for Q3 2025, versus -$13.5 billion for Q2 2025 and -$11.7 billion for Q1 2025.